Fei-Lan Liu

493 total citations
7 papers, 132 citations indexed

About

Fei-Lan Liu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Fei-Lan Liu has authored 7 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Fei-Lan Liu's work include Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and NF-κB Signaling Pathways (3 papers). Fei-Lan Liu is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and NF-κB Signaling Pathways (3 papers). Fei-Lan Liu collaborates with scholars based in Taiwan. Fei-Lan Liu's co-authors include Chia-Chung Lee, Chun‐Liang Chen, Deh‐Ming Chang, Hsu‐Shan Huang, Tsung‐Chih Chen, Ahmed Ali, Huey‐Kang Sytwu, Feng-Cheng Liu, Chang‐Youh Tsai and Jih‐Hwa Guh and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Fei-Lan Liu

7 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei-Lan Liu Taiwan 6 88 42 40 14 13 7 132
Niklas Uhlenbrock Germany 6 127 1.4× 45 1.1× 20 0.5× 10 0.7× 18 1.4× 6 164
Xiujuan Yin China 9 86 1.0× 39 0.9× 31 0.8× 36 2.6× 10 0.8× 25 224
Jitendra K. Mishra India 7 113 1.3× 103 2.5× 35 0.9× 22 1.6× 5 0.4× 20 238
Lakshminarayana Vogeti United States 7 58 0.7× 56 1.3× 33 0.8× 6 0.4× 12 0.9× 10 165
Elena Critselis Greece 5 97 1.1× 26 0.6× 28 0.7× 42 3.0× 6 0.5× 5 165
Shelby Crawford United States 5 142 1.6× 51 1.2× 84 2.1× 9 0.6× 6 0.5× 5 245
Antonella Ciavolella Italy 6 61 0.7× 33 0.8× 35 0.9× 6 0.4× 8 0.6× 15 116
Elda Meta Italy 7 79 0.9× 58 1.4× 14 0.3× 15 1.1× 4 0.3× 8 180
Bryan E. Welm United States 6 108 1.2× 48 1.1× 44 1.1× 19 1.4× 6 0.5× 7 185
Kay Huh Switzerland 7 81 0.9× 55 1.3× 22 0.6× 4 0.3× 14 1.1× 9 137

Countries citing papers authored by Fei-Lan Liu

Since Specialization
Citations

This map shows the geographic impact of Fei-Lan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei-Lan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei-Lan Liu more than expected).

Fields of papers citing papers by Fei-Lan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei-Lan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei-Lan Liu. The network helps show where Fei-Lan Liu may publish in the future.

Co-authorship network of co-authors of Fei-Lan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fei-Lan Liu. A scholar is included among the top collaborators of Fei-Lan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei-Lan Liu. Fei-Lan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Liu, Fei-Lan, Chun‐Liang Chen, Chia-Chung Lee, et al.. (2017). The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation. International Journal of Medical Sciences. 14(9). 840–852. 15 indexed citations
2.
Lee, Chia-Chung, Chun‐Liang Chen, Fei-Lan Liu, et al.. (2016). Development of 1‐Amino‐4‐(phenylamino)anthraquinone‐2‐sulfonate Sodium Derivatives as a New Class of Inhibitors of RANKL‐Induced Osteoclastogenesis. Archiv der Pharmazie. 349(5). 342–355. 5 indexed citations
3.
Chen, Chun‐Liang, Chia-Chung Lee, Fei-Lan Liu, et al.. (2016). Design, synthesis and SARs of novel salicylanilides as potent inhibitors of RANKL-induced osteoclastogenesis and bone resorption. European Journal of Medicinal Chemistry. 117. 70–84. 12 indexed citations
4.
Lee, Chia-Chung, Fei-Lan Liu, Chun‐Liang Chen, et al.. (2015). Discovery of 5-(2′,4′-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis. European Journal of Medicinal Chemistry. 98. 115–126. 32 indexed citations
5.
Lee, Chia-Chung, Fei-Lan Liu, Chun‐Liang Chen, et al.. (2015). Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. Bioorganic & Medicinal Chemistry. 23(15). 4522–4532. 22 indexed citations
6.
Chen, Chun‐Liang, Fei-Lan Liu, Chia-Chung Lee, et al.. (2014). Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents. European Journal of Medicinal Chemistry. 87. 30–38. 18 indexed citations
7.
Chen, Chun‐Liang, Fei-Lan Liu, Chia-Chung Lee, et al.. (2014). Modified Salicylanilide and 3-Phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione Derivatives as Novel Inhibitors of Osteoclast Differentiation and Bone Resorption. Journal of Medicinal Chemistry. 57(19). 8072–8085. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026